Bingjie Zhou

4PUBLICATIONS
23CO-AUTHORS
Software quality, processes and metricsGene and molecular therapyBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 21, 2021
SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation.

Shi Yu, Xu Zheng, Bingjie Zhou

|Jul 31, 2021
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.

Tingting Li, Hongmin Cai, Hebang Yao

|Mar 03, 2021
A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2.

Hebang Yao, Hongmin Cai, Tingting Li

Pageof 1